Agile Therapeutics Net Income 2013-2023 | AGRX
Agile Therapeutics net income from 2013 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Agile Therapeutics Annual Net Income (Millions of US $) |
2023 |
$-14 |
2022 |
$-25 |
2021 |
$-71 |
2020 |
$-52 |
2019 |
$-19 |
2018 |
$-20 |
2017 |
$-28 |
2016 |
$-29 |
2015 |
$-30 |
2014 |
$-16 |
2013 |
$-14 |
2012 |
$-24 |
Agile Therapeutics Quarterly Net Income (Millions of US $) |
2023-12-31 |
$-4 |
2023-09-30 |
$-1 |
2023-06-30 |
$-4 |
2023-03-31 |
$-5 |
2022-12-31 |
$-4 |
2022-09-30 |
$-6 |
2022-06-30 |
$-5 |
2022-03-31 |
$-10 |
2021-12-31 |
$-20 |
2021-09-30 |
$-17 |
2021-06-30 |
$-18 |
2021-03-31 |
$-17 |
2020-12-31 |
$-18 |
2020-09-30 |
$-16 |
2020-06-30 |
$-11 |
2020-03-31 |
$-8 |
2019-12-31 |
$-6 |
2019-09-30 |
$-4 |
2019-06-30 |
$-3 |
2019-03-31 |
$-5 |
2018-12-31 |
$-4 |
2018-09-30 |
$-4 |
2018-06-30 |
$-5 |
2018-03-31 |
$-7 |
2017-12-31 |
$-6 |
2017-09-30 |
$-7 |
2017-06-30 |
$-7 |
2017-03-31 |
$-8 |
2016-12-31 |
$-5 |
2016-09-30 |
$-8 |
2016-06-30 |
$-8 |
2016-03-31 |
$-7 |
2015-12-31 |
$-4 |
2015-09-30 |
$-9 |
2015-06-30 |
$-8 |
2015-03-31 |
$-9 |
2014-12-31 |
$-6 |
2014-09-30 |
$-6 |
2014-06-30 |
$-4 |
2014-03-31 |
$0 |
2013-12-31 |
|
2013-09-30 |
$-4 |
2013-06-30 |
$-4 |
2012-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|